Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Contemporary and optimal medical management of peripheral arterial disease. Surg Clin North Am 2013 Aug;93(4):761-78, vii

Date

07/28/2013

Pubmed ID

23885930

DOI

10.1016/j.suc.2013.04.009

Scopus ID

2-s2.0-84880699753 (requires institutional sign-in at Scopus site)   5 Citations

Abstract

Atherosclerotic lower extremity peripheral arterial disease (PAD) is a highly prevalent condition associated with a significant increase in risk of all-cause mortality and cardiovascular morbidity and mortality. PAD is underdiagnosed and undertreated. Treatment is focused on (1) lowering cardiovascular risk and cardiovascular disease event rates and (2) improvement in symptoms and quality of life. Multidisciplinary and intersociety guidelines guide optimal medical therapy. Substantial evidence supports implementation of tobacco cessation counseling and pharmacotherapy to help achieve tobacco abstinence, antiplatelet therapy, HMG-CoA reductase inhibitors (statins) therapy, and antihypertensive therapy for the purpose of lowering cardiovascular event rates and improving survival.

Author List

Tattersall MC, Johnson HM, Mason PJ

Author

Peter Mason MD Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Antihypertensive Agents
Atherosclerosis
Diabetic Angiopathies
Early Diagnosis
Exercise Therapy
Humans
Hyperlipidemias
Hypertension
Hypolipidemic Agents
Life Style
Peripheral Vascular Diseases
Platelet Aggregation Inhibitors
Practice Guidelines as Topic
Risk Factors
Smoking
Smoking Cessation